Telix names David Gill board chair
Reuters2026/08/31 22:33- Telix appointed David Gill as board chair, effective immediately.
- Gill joined the board in May 2026 as a non-executive director as part of succession planning.
- He is a life sciences executive with 35 years’ experience in biopharma and medical devices, including radiopharmaceutical development and supply chains.
- Gill previously served as CFO or president at EndoChoice Holdings, INC Research, and CTI Molecular Imaging.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japan’s Katayama: Confirmed with Bessent that continued, coordinated action on FX is needed
Renowned tech investor Gavin Baker: Data centers are creating a large number of high-paying blue-collar jobs
Baker believes that the construction of data centers can boost tax revenues in small towns and create high-paying blue-collar jobs. He also points out that the low natural gas prices in the United States provide a manufacturing cost advantage. He stated, "Learning trades like electrician, plumber, or HVAC technician now can earn you astonishing incomes, which in some cases might even surpass the net present value of going to college."
StrategX Elements extends non-brokered private placement deadline to Sept. 30, 2026
10-Yr Benchmark Govt Yields - U.S. vs Other Nations